Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.160
+0.020 (0.64%)
Jul 30, 2026, 1:40 PM EDT - Market open
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $345.05 million as of July 30, 2026. Its market cap has increased by 6.40% in one year.
Market Cap
345.05M
Enterprise Value
223.25M
1-Year Change
6.40%
Ranking
Category
Stock Price
$3.16
ChartMarket Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $345.05M, an increase of 262.07%. That is a compound annual growth rate of 11.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 345.05M | -9.17% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 366.97M |
| Abeona Therapeutics | 364.77M |
| Upstream Bio | 352.10M |
| Compass Therapeutics | 349.37M |
| DiaMedica Therapeutics | 348.09M |
| Zentalis Pharmaceuticals | 341.69M |
| Lexeo Therapeutics | 340.00M |
| Fennec Pharmaceuticals | 339.73M |